Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
This is a study of the safety and efficacy of tigecycline to ceftriaxone sodium plus
 metronidazole in hospitalized subjects with cIAI. Subjects will be followed for efficacy
 through the test-of-cure assessment. Safety evaluations will occur through the treatment and
 post-treatment periods and continue through resolution or stability of the adverse event(s).
Inclusion Criteria:

 -  Clinical diagnosis of complicated intra-abdominal infection that requires surgery
 within 24 hours.

 -  Fever plus other symptoms such as nausea, vomiting, abdominal pain.

 Exclusion Criteria:

 -  Cancer

 -  Medicines that suppress the immune system

 -  Dialysis